We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.91%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$115B
AUM Growth
+$5.45B
(+5%)
Cap. Flow
-$1.53B
Cap. Flow
% of AUM
-1.33%
Top 10 Holdings %
Top 10 Hldgs %
32.06%
Holding
343
New
9
Increased
90
Reduced
195
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$355M |
| 2 |
GSK
GSK
|
+$214M |
| 3 |
Elanco Animal Health
ELAN
|
+$128M |
| 4 |
Oracle
ORCL
|
+$116M |
| 5 |
Northern Trust
NTRS
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$472M |
| 2 |
JPMorgan Chase
JPM
|
+$436M |
| 3 |
Bank of America
BAC
|
+$232M |
| 4 |
Eli Lilly
LLY
|
+$177M |
| 5 |
KLA
KLAC
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.75% |
| 2 | Technology | 29.46% |
| 3 | Industrials | 11.99% |
| 4 | Consumer Discretionary | 9.22% |
| 5 | Financials | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.07T
| $8.71B | 7.6% |
25,367,550
-524,475
| -2% | -$177M |
|
2
Biogen
BIIB
$29.5B
| $4.45B | 3.88% |
16,001,166
+300,590
| +2% | +$83.2M |
|
3
Amgen
AMGN
$203B
| $3.65B | 3.19% |
15,112,703
-179,510
| -1% | -$44.1M |
|
|
4
Microsoft
MSFT
$2.89T
| $3.3B | 2.88% |
11,441,058
-1,848,630
| -14% | -$472M |
|
5
AstraZeneca
AZN
$263B
| $3.15B | 2.75% |
22,694,929
+201,509
| +0.9% | +$27.1M |
|
6
FedEx
FDX
$73.5B
| $3.1B | 2.7% |
13,568,892
-353,075
| -3% | -$71.7M |
|
7
Texas Instruments
TXN
$255B
| $3.1B | 2.7% |
16,644,445
-440,245
| -3% | -$77.4M |
|
|
8
KLA
KLAC
$266B
| $2.53B | 2.21% |
63,498,890
-4,220,650
| -6% | -$166M |
|
9
Adobe
ADBE
$94.5B
| $2.43B | 2.11% |
6,293,153
-48,520
| -0.8% | -$17.2M |
|
10
Micron Technology
MU
$1.02T
| $2.35B | 2.05% |
38,949,937
-789,660
| -2% | -$46.3M |
|
|
11
Intel
INTC
$462B
| $2.26B | 1.97% |
69,103,171
+12,531,210
| +22% | +$355M |
|
12
Sony
SONY
$131B
| $2.18B | 1.9% |
120,124,790
-1,702,755
| -1% | -$29.5M |
|
13
Alphabet (Google) Class A
GOOGL
$3.99T
| $2.16B | 1.88% |
20,781,745
-312,080
| -1% | -$29.9M |
|
14
Thermo Fisher Scientific
TMO
$208B
| $2.05B | 1.79% |
3,564,109
-94,465
| -3% | -$53.2M |
|
15
Tesla
TSLA
$1.22T
| $2.05B | 1.79% |
9,878,900
-171,475
| -2% | -$29.9M |
|
16
Boston Scientific
BSX
$67.6B
| $1.92B | 1.67% |
38,328,229
+676,370
| +2% | +$31.9M |
|
17
BioMarin Pharmaceuticals
BMRN
$11.6B
| $1.77B | 1.55% |
18,243,429
+662,570
| +4% | +$68.7M |
|
18
Wells Fargo
WFC
$264B
| $1.77B | 1.54% |
47,378,950
-331,255
| -0.7% | -$14.4M |
|
19
Alibaba
BABA
$276B
| $1.77B | 1.54% |
17,283,277
+4,650
| +0% | +$466K |
|
20
Southwest Airlines
LUV
$22.2B
| $1.65B | 1.44% |
50,852,629
-1,345,470
| -3% | -$45.8M |
|
21
Novartis
NVS
$297B
| $1.51B | 1.32% |
16,427,035
-767,845
| -4% | -$67.1M |
|
22
Bristol-Myers Squibb
BMY
$128B
| $1.49B | 1.3% |
21,514,405
-342,160
| -2% | -$24.1M |
|
|
23
Alphabet (Google) Class C
GOOG
$3.99T
| $1.43B | 1.25% |
13,744,985
-490,570
| -3% | -$47.4M |
|
24
Baidu
BIDU
$35.8B
| $1.42B | 1.23% |
9,382,524
-87,960
| -0.9% | -$12.5M |
|
25
Aecom
ACM
$9.12B
| $1.36B | 1.19% |
16,116,639
-1,473,032
| -8% | -$127M |
|
Similar funds
Primecap Management's Q1 2023 Portfolio in Review
As of Q1 2023, Primecap Management held 343 positions worth $115B, up 5% from $109B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Primecap Management's Q1 2023 filing shows 9 new, 90 increased, 195 reduced and 12 closed positions. Its largest new stake was Trade Desk: 767,800 shares worth $46.8M. The largest sale was Microsoft, an estimated $472M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q1 2023 buy was Trade Desk: 767,800 shares worth $46.8M.
- Primecap Management added most to Intel in Q1 2023, an estimated $355M increase.
- Primecap Management's biggest Q1 2023 reduction was Microsoft, cutting an estimated $472M.
- Primecap Management fully exited Sphere Entertainment in Q1 2023, selling an estimated $28.9M.
- Primecap Management's ten largest holdings make up 32% of its $115B portfolio in Q1 2023.
- Primecap Management opened 9 new positions and closed 12 in Q1 2023.
- Primecap Management's portfolio value rose 5% quarter-over-quarter to $115B.
Based on Primecap Management's 13F filing for Q1 2023, filed 15 May 2023.